⌘K

Login Start Free

Home/Filings/4/0001181431-12-005295

4//SEC Filing

OCLASSEN GLENN A 4

Accession 0001181431-12-005295

CIK 0001178711other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:34 PM ET

Size

5.3 KB

Accession

0001181431-12-005295

Insider Transaction Report

Form 4

Period: 2012-02-01

Transcept Pharmaceuticals IncTSPT

OCLASSEN GLENN A

DirectorPresident and CEO

Transactions

Award
Employee Stock Option (right to buy)
2012-02-01+180,000→ 180,000 total
Exercise: $8.09Exp: 2022-02-01→ Common Stock (180,000 underlying)

Footnotes (1)

[F1]The option vests in forty-eight equal monthly installments beginning on March 1, 2012.

Documents

1 file

4
rrd332252.xmlPrimary
OCLASSEN ANNUAL GRANT

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

Entity typeother

Related Parties

1

filerCIK 0001210529

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 4:34 PM ET
Size: 5.3 KB

View on SEC.gov